What Is the PSCH ETF? A Complete Guide to Returns, Expense Ratio, Holdings and Alternative ETFs
The Invesco S&P SmallCap Health Care ETF (PSCH) invests in a concentrated portfolio of US small-cap health care companies. It spreads exposure across small-cap biotech, pharmaceutical and medical device stocks, and the key selection criteria are how its market-cap exposure and dividends differ from large-cap health care ETFs such as XLV and VHT.
What Is the Invesco S&P SmallCap Health Care ETF?
This is a passive ETF that tracks the S&P SmallCap 600 Health Care Index and diversifies across US small-cap health care companies. It covers a wide range of sub-industries, including biotech, pharmaceuticals, medical devices and health care facilities.
It suits investors who want to focus on the health care sector while accepting both the high growth potential and the volatility of small-cap stocks.
The ETF is managed by Invesco using a passive (index-tracking) approach.
How Does the Invesco S&P SmallCap Health Care ETF Invest?
| Item | Details |
|---|---|
| Tracked Index | S&P SmallCap 600 Health Care Index |
| Management Style | Passive (index-tracking) |
| Rebalancing Frequency | Quarterly |
| Dividend Frequency | Quarterly |
| Manager | Invesco |
| Expense Ratio | 0.29% |
The fund holds US small-cap health care companies in the index at their market-cap weights and tracks the performance of that sector. It does not actively pick individual stocks. Holdings are added or removed automatically as the index changes, and because of the nature of small caps, weights are spread across many individual companies.
- Focuses on small-cap health care companies rather than large caps
- Broad diversification across sub-industries including biotech, pharmaceuticals and medical devices
Invesco S&P SmallCap Health Care ETF Size and Costs (AUM and Management Fee)
Assets under management (AUM) stand at $186.0M, and the expense ratio is 0.29% per year.
Compared with the large-cap health care ETFs XLV and VHT, it concentrates on smaller companies with lower market-cap exposure, so both its growth potential and its volatility tend to be high.
Invesco S&P SmallCap Health Care ETF Performance and Trends
The ETF moves in line with the health care sector. With a large weighting in small-cap biotech in particular, it tends to be highly volatile depending on clinical trial results and the interest rate environment. Its price swings tend to be wider than those of large-cap ETFs.
Small caps and biotech tend to attract inflows when risk appetite is strong, and fund flows can shift with interest rates and overall sector sentiment. Flows are generally more volatile than those of large-cap core ETFs.
Invesco S&P SmallCap Health Care ETF Pros and Cons
The high growth potential of small-cap health care is its strength, while volatility and cost are considered its drawbacks.
💪 Key Strengths
⚠️ Points to Watch
Invesco S&P SmallCap Health Care ETF Alternatives and Related Products
ETFs shown in the table such as XLV, VHT, FHLC and IYH are broad health care products weighted toward large caps, and their market-cap composition differs from the small-cap exposure of PSCH. XBI in the same table is an equal-weighted product focused on biotech. You can also consider sub-industry ETFs such as IBB, which has a larger weighting in large-cap biotech, IHI, which specializes in medical devices, and PPH, which focuses on pharmaceuticals.
| Ticker | Name | Price | Change | AUM | Total Expense Ratio | Dividend Yield | 1Y |
|---|---|---|---|---|---|---|---|
| State Street Health Care Select Sector SPDR ETF | $181.17 | -2.2% | $49.6B | 0.08% | 1.41% | +18.7% | |
| Vanguard Health Care ETF | $334.34 | -2.0% | $21.0B | 0.09% | 1.38% | +17.8% | |
| State Street SPDR S&P Biotech ETF | $145.04 | -0.2% | $9.7B | 0.35% | 0.38% | +25.9% | |
| iShares U.S. Healthcare ETF | $75.75 | -2.1% | $4.8B | 0.37% | 1.05% | +18.0% | |
| Fidelity MSCI Health Care Index ETF | $86.45 | -2.0% | $4.1B | 0.08% | 1.18% | +18.2% |
| Ticker | Name | Weight | Price | Change | Market Cap | P/E | Dividend Yield |
|---|---|---|---|---|---|---|---|
| OmniAb Inc | - | $5.08 | +0.6% | $741.0M | - | - | |
| Corcept Therapeutics Inc | 0.06% | $67.79 | -3.3% | $7.4B | 53.5 | - | |
| Glaukos Corp | 0.05% | $233.08 | -4.2% | $13.8B | - | - | |
| Molina Healthcare Inc | 0.05% | $206.56 | -6.6% | $10.8B | - | - | |
| Protagonist Therapeutics Inc | 0.05% | $127.16 | +2.0% | $8.3B | 26.9 | - |
Invesco S&P SmallCap Health Care ETF Investor Checkpoints
Here are the points to review before investing in PSCH. Because this ETF focuses on small-cap health care, it is wise to check volatility, costs and sector concentration carefully in advance, more so than with a typical large-cap ETF.
| Checkpoint | What to Check | Current Status |
|---|---|---|
| 💵 Expense Ratio | Check the impact of cumulative costs over a long holding period | Higher than core ETFs |
| 📈 Volatility | Price swings driven by the small-cap biotech weighting | High |
| 📊 Sector Concentration | Exposure to the single health care sector | Concentrated in a single sector |
| 💱 Exchange Rate | Impact on returns when converted to Korean won | No currency hedge applied |
The main risk is high volatility from the weighting in small caps and biotech. Clinical trial failures, rising interest rates or a slowdown in the sector could cause larger losses than large-cap ETFs, so position sizing is important.
It is a suitable choice for investors who want to focus on small-cap health care growth stocks. If you want lower volatility and more stable sector exposure, you could also consider large-cap core health care ETFs such as XLV and VHT, or XBI if you want a greater focus on biotech.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. All investment responsibility lies with the investor.
This article reflects information as of June 25, 2026.